28 studies found for:    Open Studies | "Encephalitis"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Recruiting Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
Condition: Japanese Encephalitis
Intervention: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)
3 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
4 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
5 Recruiting Tick-borne Encephalitis and Positive Borrelial Antibodies
Condition: Tick-borne Encephalitis
Interventions: Drug: Doxycycline;   Drug: Symptomatic therapy;   Other: Questionnaire
6 Unknown  Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
7 Recruiting Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
Condition: Japanese Encephalitis
Intervention: Biological: Inactivated Japanese encephalitis vaccine (Beijing-Handai strain, cell-cultured)
8 Not yet recruiting Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis
Condition: Encephalitis
Interventions: Drug: Immunoglobulins, Intravenous (Privigen);   Drug: Placebo
9 Not yet recruiting Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
Condition: Encephalitis, Japanese
Intervention: Biological: SA-14-14-2 live, attenuated JE vaccine
10 Recruiting tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis
Conditions: Multiple Sclerosis;   Encephalitis
Intervention: Device: Transcranial direct current stimulation
11 Not yet recruiting Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine
Condition: Western Equine Encephalitis
Intervention: Biological: Western Equine Encephalitis (WEE) Vaccine
12 Recruiting New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
13 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
14 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
15 Recruiting Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis
Condition: Anti-NMDA Receptor Encephalitis
Interventions: Device: tDCS;   Device: Sham Stimulation
16 Recruiting Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area
Condition: Anti-N-Methyl-D-Aspartate Receptor Encephalitis
17 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
18 Recruiting Brain Inflammation and Function in Alcoholism
Condition: Alcoholism
Interventions: Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
19 Recruiting Brain Inflammation in Major Depressive Disorder Background
Condition: Major Depression
20 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years